FDA approves Zohydro, first hydrocodone-only painkiller
It’s been a long ride for Zohydro ER and its California-based pharmaceutical firm Zogenix, but the journey is nearing an end. Zohydro ER will be the first extended-release, hydrocodone-only painkiller to reach the market, expected in approximately four months. On October 25, the FDA officially approved this highly controversial drug to treat severe chronic pain that is unresponsive to alternative therapies. … Read More